This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


Empagliflozin

From Proteopedia

Jump to: navigation, search

Caption for this structure

Drag the structure with the mouse to rotate

References

  1. ↑ Abdul-Ghani MA, DeFronzo RA. Inhibition of renal glucose reabsorption: a novel strategy for achieving glucose control in type 2 diabetes mellitus. Endocr Pract. 2008 Sep;14(6):782-90. PMID:18996802 doi:10.4158/EP.14.6.782
  2. ↑ Nair S, Wilding JP. Sodium glucose cotransporter 2 inhibitors as a new treatment for diabetes mellitus. J Clin Endocrinol Metab. 2010 Jan;95(1):34-42. PMID:19892839 doi:10.1210/jc.2009-0473
  3. ↑ Bays H. From victim to ally: the kidney as an emerging target for the treatment of diabetes mellitus. Curr Med Res Opin. 2009 Mar;25(3):671-81. PMID:19232040 doi:10.1185/03007990802710422

Proteopedia Page Contributors and Editors (what is this?)

Alexander Berchansky

Retrieved from "http://52.214.119.220/wiki/index.php/Empagliflozin"
Personal tools